{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:13:07Z","timestamp":1761919987046,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.msard.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T23:30:16Z","timestamp":1431559816000},"page":"377-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The effect of dimethyl fumarate (Tecfidera\u2122) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk"],"prefix":"10.1016","volume":"4","author":[{"given":"Bhupendra O.","family":"Khatri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Sershon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayo","family":"Olapo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8007-7256","authenticated-orcid":false,"given":"Jean","family":"Sesing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Dukic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Rehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"67","key":"10.1016\/j.msard.2015.05.003_bib9","first-page":"495","article-title":"The pathogenesis of progressive multifocal leukoencephalopathy","volume":"12","author":"Berger","year":"2012","journal-title":"Discov. Med."},{"issue":"17","key":"10.1016\/j.msard.2015.05.003_bib6","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMc1211805","article-title":"PML in a patient treated with fumaric acid","volume":"368","author":"Ermis","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.msard.2015.05.003_bib3","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2015.05.003_sbref5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-199921020-00003","article-title":"Drug-induced lymphopenia: focus on CD4+ and CD8+ cells","volume":"21","author":"Gergely","year":"1999","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.msard.2015.05.003_sbref6","first-page":"91","article-title":"An association between low CD8 cells and infection is less clear (Gergely P. Drug-induced lymphopenia: focus on CD4+ and CD8+ cells","volume":"21","year":"1999","journal-title":"Drug Saf."},{"issue":"12","key":"10.1016\/j.msard.2015.05.003_bib2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.msard.2015.05.003_bib10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJMc1307680","article-title":"Case reports of PML in patients treated for psoriasis","volume":"369","author":"Mrowietz","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.msard.2015.05.003_bib5","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1056\/NEJMc1215357","article-title":"PML in a patient treated with dimethyl fumarate from a compounding pharmacy","volume":"368","author":"van Oosten","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2015.05.003_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.jid.5700996","article-title":"Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression","volume":"128","author":"Rubant","year":"2008","journal-title":"J. Invest. Dermatol"},{"issue":"2","key":"10.1016\/j.msard.2015.05.003_bib1","article-title":"Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate","author":"Spencer","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034815000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:38:39Z","timestamp":1761899919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034815000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2211034815000632"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2015.05.003","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of dimethyl fumarate (Tecfidera\u2122) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}